510(k) K990023

HYBRID CAPTURE II CT-ID TEST by Digene Corp. — Product Code LSK

K990023 is an FDA 510(k) premarket notification submitted by Digene Corp. for the device "HYBRID CAPTURE II CT-ID TEST". The FDA issued a decision of Substantially Equivalent on October 25, 1999. The device falls under product code LSK (Dna-Reagents, Chlamydia), a Class I device regulated under 21 CFR 866.3120. Digene Corp. has at least 8 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
October 25, 1999
Date Received
January 5, 1999
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Dna-Reagents, Chlamydia
Device Class
Class I
Regulation Number
866.3120
Review Panel
MI
Submission Type